Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb 2;2(2):CD005540.
doi: 10.1002/14651858.CD005540.pub3.

Interventions for sexual dysfunction following treatments for cancer in women

Bridget Candy  1 , Louise Jones, Victoria Vickerstaff, Adrian Tookman, Michael King
Affiliations

Interventions for sexual dysfunction following treatments for cancer in women

Bridget Candy et al. Cochrane Database Syst Rev. .

Abstract

Background: The proportion of people living with and surviving cancer is growing. This has led to increased awareness of the importance of quality of life, including sexual function, in those affected by cancer. Sexual dysfunction is a potential long-term complication of many cancer treatments. This includes treatments that have a direct impact on the pelvic area and genitals, and also treatments that have a more generalised (systemic) impact on sexual function.This is an update of the original Cochrane review published in Issue 4, 2007, on interventions for treating sexual dysfunction following treatments for cancer for men and women. Since publication in 2007, there has been an increase in the number of trials for both men and women and this current review critiques only those for women. A review in press will present those for men.

Objectives: To evaluate the effectiveness of interventions for treating sexual dysfunction in women following treatments for cancer. To assess adverse events associated with interventions.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2015, Issue 9), MEDLINE, EMBASE, PsycINFO, AMED, CINAHL, Dissertation Abstracts and the NHS Research Register. The searches were originally run in January 2007 and we updated these to September 2015.

Selection criteria: We included randomised controlled trials (RCTs) that assessed the effectiveness of a treatment for sexual dysfunction. The trial participants were women who had developed sexual dysfunction as a consequence of a cancer treatment. We sought evaluations of interventions that were pharmaceutical, mechanical, psychotherapeutic, complementary or that involved physical exercise.

Data collection and analysis: Two review authors independently extracted the data and assessed trial quality. We considered meta-analysis for trials with comparable key characteristics.

Main results: Since the original version of this review we have identified 11 new studies in women. The one study identified in the earlier version of this review was excluded in this update as it did not meet our narrower inclusion criteria to include only interventions for the treatment, not prevention, of sexual dysfunction.In total 1509 female participants were randomised across 11 trials. All trials explored interventions following treatment either for gynaecological or breast cancer. Eight trials evaluated a psychotherapeutic or psycho-educational intervention. Two trials evaluated a pharmaceutical intervention and one pelvic floor exercises. All involved heterosexual women. Eight studies were at a high risk of bias as they involved a sample of fewer than 50 participants per trial arm. The trials varied not only in intervention content but in outcome measurements, thereby restricting combined analysis. In the trials evaluating a psychotherapeutic intervention the effect on sexual dysfunction was mixed; in three trials benefit was found for some measures of sexual function and in five trials no benefit was found. Evidence from the other three trials, two on different pharmaceutical applications and one on exercise, differed and was limited by small sample sizes. Only the trial of a pH-balanced vaginal gel found significant improvements in sexual function. The trials of pharmaceutical interventions measured harm: neither reported any. Only one psychological intervention trial reported that no harm occurred because of the intervention; the other trials of psychological support did not measure harm.

Authors' conclusions: Since the last version of this review, the new studies do not provide clear information on the impact of interventions for sexual dysfunction following treatments for cancer in women. The sexual dysfunction interventions in this review are not representative of the range that is available for women, or of the wider range of cancers in which treatments are known to increase the risk of sexual problems. Further evaluations are needed.

PubMed Disclaimer

Conflict of interest statement

BC has no relevant conflicts of interest to declare. VV has no relevant conflicts of interest to declare. AT has no relevant conflicts of interest to declare. MK and LJ are grant holders on a ongoing funded NIHR pilot randomised trial of a stepped care intervention for women with sexual dysfunction after treatment for gynaecological cancer.

Figures

1
1
Study flow diagram.
2
2
'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Aktas 2015 {published data only}
    1. Aktas D, Terzioglu F. Effect of home care service on the sexual satisfaction of patients with gynecologic cancer. Sexuality and Disability 2015;33(2):243-52. [10.1007/s11195-014-9370-8]
Barton 2007 {published data only}
    1. Barton DL, Wender DB, Sloan JA, Dalton RJ, Balcueva EP, Atherton PJ, et al. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group Protocol N02C3. Journal of the National Cancer Institute 2007;99:672-9. - PubMed
Baucom 2009 {published data only}
    1. Baucom DH, Porter LS, Kirby JS, Gremore TM, Wiesenthal N, Aldridge W, et al. A couple-based intervention for female breast cancer. Psycho-Oncology 2009;18:276-83. - PubMed
Classen 2013 {published data only}
    1. Classen CC, Chivers ML, Urowitz S, Barbera L, Wiljer D, O'Rinn S, et al. Psychosexual distress in women with gynaecologic cancer: a feasibility study of an online support group. Psycho-Oncology 2013;22:930-5. - PubMed
Lee 2011 {published data only}
    1. Lee YK, Chung HH, Kim JW, Park NH, Song YS, Kang SB. Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: a randomised controlled trial. Obstetrics and Gynecology 2011;117:922-7. - PubMed
Marcus 2010 {published data only}
    1. Marcus AC, Garrett KM, Cella D, Wenzal L, Brady MJ, Fairclough D, et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psycho-Oncology 2010;19:923-32.
Rowland 2009 {published data only}
    1. Rowland JH, Meyerowitz BE, Crespi CM, Leedham B, Desmond K, Belin TR, et al. Addressing intimacy and partner communication after breast cancer: a randomised controlled group intervention. Breast Cancer Research and Treatment 2009;118:99-111. - PMC - PubMed
Schover 2011 {published data only}
    1. Schover LR, Rhodes MM, Baum G, Harned Adams J, Jenkins R, Lewis P, et al. Sisters Peer Counseling in Reproductive Issues After Treatment (SPIRIT). Cancer 2011;117:4983-92. - PMC - PubMed
Schover 2013 {published data only}
    1. Schover LR, Yuan Y, Fellman BM, Odensky E, Lewis PE, Marinetti P. Efficacy trial of an internet-based intervention for cancer-related female sexual dysfunction. Journal of the National Comprehensive Cancer Network 2013;11:1389-97. - PMC - PubMed
Svensk 2009 {published data only}
    1. Öster I, Tavelin B, Thyme KE, Magnusson E, Isaksson U, Lindh J, et al. Art therapy during radiotherapy – a five-year follow-up study with women diagnosed with breast cancer. The Arts in Psychotherapy 2014;41:36-40.
    1. Svensk A-C, Öster I, Thyme KE, Magnusson E, Sjodin M, Eisemann M, et al. Art therapy improves experienced quality of life among women undergoing treatment for breast cancer: a randomized controlled study. European Journal of Cancer Care 2009;18:69-77. - PubMed
Yang 2012 {published data only}
    1. Yang EJ, Lim JY, Rah UW, Kim YB. Effect of a pelvic floor muscle training program on gynaecologic cancer survivors with pelvic floor dysfunction: a randomized controlled trial. Gynecologic Oncology 2012;125:705-11. - PubMed

References to studies excluded from this review

Badger 2005 {published data only}
    1. Badger T, Segrin C, Meek P, Lopez AM, Bonham E, Sieger A. Telephone interpersonal counselling with women with breast cancer: symptom management and quality of life. Oncology Nursing Forum 2005;32:273-9. - PubMed
Barber 2002 {published data only}
    1. Barber MD, Visco AG, Wyman JF, Fantyl JA, Bump RC. Sexual function in women with urinary incontinence and pelvic organ prolapse. American College of Obstetrics and Gynecologists 2002;99:281-9. - PubMed
Barrett‐Connor 1996 {published data only}
    1. Barrett CE, Timmons C, Young R, Wiita B. Interim safety analysis of a two-year study comparing oral estrogen-androgen and conjugated estrogens in surgically menopausal women. Journal of Women's Health 1996;5:593-602.
Berman 2003 {published data only}
    1. Berman JR, Berman LA, Toler SM, Gill J, Haughie S. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study. Journal of Urology 2003;170:2333-8. - PubMed
Boesen 2011 {published data only}
    1. Boesen EH, Karlsen R, Christensen J, Paaschburg B, Nielsen D, Bloch IS, et al. Psychosocial group intervention for patients with primary breast cancer: a randomised trial. European Journal of Cancer 2011;47:1363-72. - PubMed
Brotto 2012 {published data only}
    1. Brotto LA, Erskine Y, Carey M, Ehlen T, Finlayson S, Heywood M, et al. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer. Gynecologic Oncology 2012;125:320-5. - PMC - PubMed
Burstein 1999 {published data only}
    1. Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. New England Journal of Medicine 1999;340:1733-9. - PubMed
Chow 2014 {published data only}
    1. Chow KM, Chan CWH, Chan JCCY, Choi KKC, Siu KY. A feasibility study of a psycho-educational intervention program for gynaecological cancer patients. European Journal of Oncology Nursing 2014;18:385-92. - PubMed
Christensen 1983 {published data only}
    1. Christensen DN. Postmastectomy couple counselling: an outcome study of a structures treatment protocol. Journal of Sex & Marital Therapy 1983;9:266-75. - PubMed
Davis 2004 {published data only}
    1. Davis C. Psychosocial needs of women with breast cancer: how can social workers make a difference? Health and Social Work 2004;29:330-4. - PubMed
Decruze 1999 {published data only}
    1. Decruze SB, Gutherie D, Magnai R. Prevention of vaginal stenosis in patients following vaginal brachytherapy. Clinical Oncology 1999;11:46-8. - PubMed
Dennerstein 1979 {published data only}
    1. Dennerstein L, Burrows GD, Hyman GJ, Sharpe K. Some clinical effects of oestrogen-progestogen therapy in surgically castrated women. Maturitas 1979;2:19-28. - PubMed
Doorenbos 2006 {published data only}
    1. Doorenbos A, Given B, Given C, Verbitsky N. Effect of behavioural intervention for symptoms among individuals with cancer. Nursing Research 2006;55:161-71. - PMC - PubMed
Floter 2002 {published data only}
    1. Floter A, Nathorst-Boos, Carlstrom K, von Schoultz. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric 2002;5(4):357-65. - PubMed
Ganz 2000 {published data only}
    1. Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. Journal of the National Cancer Institute 2000;92:1054-64. - PubMed
Given 2004 {published data only}
    1. Given C, Given B, Rahbar M, Jeon S, McCorkle R, Cimprich B, et al. Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. Journal of Clinical Oncology 2004;22:507-16. - PubMed
Goetsch 2014 {published data only}
    1. Goetsch MF, Lim JY, Caughey AB. Locating pain in breast cancer survivors experiencing dyspareunia: a randomized controlled trial. Obstetrics & Gynecology 2014;123:1231-6. - PubMed
Hasenbring 1999 {published data only}
    1. Hasenbring M, Schulz KF, Hennings U, Florian M, Linhart D, Ramm G, et al. The efficacy of relaxation/imagery, music therapy and psychological support for pain relief and quality of life: first results from a randomized controlled clinical trial [abstract]. Bone Marrow Transplant 1999;23:166.
Huang 2013 {published data only}
    1. Huang G, Basaria S, Travison TG, Ho MH, Davda M, Mazer NA, et al. Testosterone does-relationships in hysterectomised women with or without oopherctomy: effects on sexual function, body composition, muscle performance and physical function in a randomised trial. Journal of the North American Menopause Society 2013;21:612-23. - PMC - PubMed
Izuo 1967 {published data only}
    1. Izuo M, Fujimori M. Studies on hormonal treatment for mastopathy, particularly its dose-response relationship. Endocrinologia Japonica 1967;14:27-33. - PubMed
Jefferies 2006 {published data only}
    1. Jefferies SA, Robinson JW, Craighead PS, Keats M. An effective group psycho-educational intervention for improving compliance with vaginal dilation: a randomized controlled trial. International Journal of Radiation Oncology, Biology, Physics 2006;65:404-11. - PubMed
Jones 2006 {published data only}
    1. Jones RB, Pearson J, Cawsey AJ, Bental D, Barrett A, White J, et al. Effect of different forms of information produced for cancer patients on their use of the information, social support and anxiety: randomised trial. BMJ 2006;332:942-8. - PMC - PubMed
Jung Hoon 2006 {published data only}
    1. Jong-Hoon K, Park CY, Sung-Jae L. Effects of Sun Ginseng on subjective quality of life in cancer patients: a double-blind, placebo-controlled pilot trial. Journal of Clinical Pharmacy and Therapeutics 2006;31:331-4. - PubMed
Juraskova 2013 {published data only}
    1. Juraskova I, Jarvis S, Mok K, Peate M, Meiser B, Cheah BC, et al. The acceptability, feasibility, and efficacy (phase I/II study) of the OVERcome (Olive Oil, Vaginal Exercise, and MoisturizeR) intervention to improve dyspareunia and alleviate sexual problems in women with breast cancer. International Society for Sexual Medicine 2013;10(10):2549-58. - PubMed
Kylstra 1999 {published data only}
    1. Kylstra WA, Leenhouts GHMW, Everaerd W, Panneman MJM, Hahn DEE, Weijmar-Schultz WCM, et al. Sexual outcomes following treatment for early-stage gynaecological cancer: a prospective and cross-sectional multi-center study. International Journal of Gynecological Cancer 1999;9:387-95. - PubMed
Lengacher 2009 {published data only}
    1. Lengacher CA, Johnson-Mallard V, Post-White J, Moscoso MS, Jacobsen PB, Klein TW, et al. Randomized controlled trial of mindfulness-based stress reduction (MBSR) for survivors of breast cancer. Psycho-Oncology 2009;18:1261-77. - PubMed
Lepore 2015 {published data only}
    1. Lepore SJ, Revenson TA. Randomised controlled trial of expressive writing and quality of life in men and women treated for colon or rectal cancer. Psychology and Health 2015;30:284-300. - PMC - PubMed
Loprinzi 2011 {published data only}
    1. Loprinzi C, Balcueva EP, Liu H, Sloan JA, Kottschade LA, Stella PJ, et al. A phase III randomised, double blind, placebo-controlled study of pilocarpine for vaginal dryness: NCCTG study N04CA. Journal of Supportive Oncology 2011;9:105-12. - PMC - PubMed
Marsden 2001 {published data only}
    1. Marsden J, Baum M, A'Hern R, West A, Fallowfield L, Whitehead M, et al. The impact of hormone replacement therapy on breast cancer patients' quality of life and sexuality. Journal of the British Menopause 2001;7:85-91.
Moore 1999 {published data only}
    1. Moore RA. Livial: a review of clinical studies. British Journal of Obstetrics and Gynecology 1999;106:1-21. - PubMed
Morales 2004 {published data only}
    1. Morales L, Neven P, Timmerman D, Christiaens MR, Vergote I, Van Limbergen E, et al. Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Clinical Report 2004;15:753-60. - PubMed
Mulhall 2006 {published data only}
    1. Mulhall JP. Neuromodulatory drugs in a radical pelvic surgery patient. Journal of Sexual Medicine 2006;3:77-9.
Munarriz 2002 {published data only}
    1. Munarriz R, Talakoub L, Flaherty E, Gioia M, Hoag L, Kim NN, et al. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results. Journal of Sex and Marital Therapy 2002;28 Suppl 1:165-73. - PubMed
Munstedt 1998 {published data only}
    1. Munstedt K, Milch W, Reimer C. Epicutaneous breast forms after mastectomy. Support Care Cancer 1998;6:295-9. - PubMed
Narvaez 2008 {published data only}
    1. Narvaez A, Rubinos C, Cortes-Funes F, Gomez R, Garcia A. Rating of the effectiveness of group therapy cognitive image in body, self-esteem, sexual distress, and anxiety and depression in breast cancer patients. [Spanish]. Psicooncologica 2008;5:93-102.
Nho 2013 {published data only}
    1. Nho JH. Effect of PLISSIT model sexual health enhancement program for women with gynecologic cancer and their husbands. Journal of the Korean Academy of Nursing 2013;43(5):681-9. - PubMed
Nieman 2003 {published data only}
    1. Nieman LK. Management of surgically hypogonadal patients unable to take sex hormone replacement therapy. Endocrinology and Metabolism Clinics of North America 2003;32:325-36. - PubMed
Nikander 2003 {published data only}
    1. Nikander E, Kilkkinen A, Metsa HM, Adlercreutz H, Pietinen P, Tiitinen A, et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. American College of Obstetricians and Gynecologists 2003;101:1213-20. - PubMed
Northouse 2002 {published data only}
    1. Northouse LL, Walker J, Schafenacker A, Mood D, Mellon S, Galvin E, et al. A family-based program of care for women with recurrent breast cancer and their family members. Oncology Nursing Forum 2002;29:1411-9. - PubMed
Northouse 2013 {published data only}
    1. Northouse LL, Mood DW, Schafenacker A, Kalemkerian G, Zalupski M, LoRussi P, et al. Randomised clinical trial of a brief and extensive dyadic intervention for advanced cancer patients and their family caregivers. Psycho-Oncology 2013;22:555-63. - PMC - PubMed
Park 2015 {published data only}
    1. Park HY, Kim JH, Choi S, Kang E, Kim JY, Kim SW. Psychological effects of a cosmetic education programme in patients with breast cancer. European Journal of Cancer Care 2015;24:493-502. - PubMed
Pietrzak 2007 {published data only}
    1. Pietrzak L, Bujko K, Nowacki MP, Kepka L, Oledzki J, Rutkowski A, et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trial. Radiotherapy and Oncology 2007;84:217-25. - PubMed
Pitkin 1971 {published data only}
    1. Pitkin RM, VanVoorhis LW. Postirradiation vaginitis. Therapeutic Radiology 1971;99:417-21. - PubMed
Ponzone 2005 {published data only}
    1. Ponzone R, Biglia N, Jacomuzzi ME, Maggiorotto F, Mariani L, Sismondi P. Vaginal oestrogen therapy after breast cancer: is it safe? European Journal of Cancer 2005;41:2673-81. - PubMed
Rawlins 1999 {published data only}
    1. Rawlins S, Burkman RT, Schwarz BE. The power of the pill: making evidence-based decisions. American Journal for Nurse Practitioners 2000;4:25-40.
Reese 2014 {published data only}
    1. Reese JB, Porter LS, Regan KR, Keefe FJ, Azad NS, Diaz LA, et al. A randomized pilot trial of a telephone-based couples intervention for physical intimacy and sexual concerns in colorectal cancer. Psycho-Oncology 2014;23:1005-13. - PMC - PubMed
Robinson 1999 {published data only}
    1. Robinson JW, Faris PD, Scott CB. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynaecological carcinoma treated with radiotherapy. International Journal of Radiation Oncology, Biology, Physics 1999;44:497-506. - PubMed
Schover 2006 {published data only}
    1. Schover LR, Jenkins R, Sui D, Adams JH, Marion MS, Jackson KE. Randomized trial of peer counseling on reproductive health in African American breast cancer survivors. Journal of Clinical Oncology 2006;24:1620-6. - PubMed
Schroder 2005 {published data only}
    1. Schroder M, Mell LK, Hurteau JA, Collins YC, Rotmensch J, Waggoner SE, et al. Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. International Journal of Radiation Oncology , Biology , Physics 2005;61:1078-86. - PubMed
Scott 2004 {published data only}
    1. Scott JL, Ward BG. United we stand? The effects of a couple-coping intervention on adjustment to early stage breast or gynecological cancer. Journal of Consulting and Clinical Psychology 2004;72:1122-35. - PubMed
Seidman 2000 {published data only}
    1. Seidman SN. Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women. Current Psychiatry Reports 2000;2:215-22. - PubMed
Serewel 1990 {published data only}
    1. Serewel A, Haggie JA, Cade D. A randomised controlled trial of medroxyprogesterone acetate in mastalgia. Annals of the Royal College of Surgeons of England 1990;72:273. - PMC - PubMed
Shabani 2014 {published data only}
    1. Shabani M, Moghimi M, Zamiri RE, Nazari F, Mousavinasab N, Shajari Z. Life skills training effectiveness on non-metastatic breat cancer mental health: a clinical trial. Iranian Red Crescent Medical Journal 2014;16:E8763. - PMC - PubMed
Sherwin 1984 {published data only}
    1. Sherwin BB, Gelfand MM. Effects of parenteral administration of estrogen and androgen on plasma hormone levels and hot flushes in the surgical menopause. American Journal of Obstetrics and Gynecology 1984;148:552-7. - PubMed
Sherwin 1985 {published data only}
    1. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosomatic Medicine 1985;4:339-51. - PubMed
Shifren 2000a {published data only}
    1. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, et al. The efficacy of sildenafil citrate (Viagra) in clinical populations: an update. New England Journal of Medicine 2000;343:682-8.
Suckling 2006 {published data only}
    1. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No: CD001500. [DOI: 10.1002/14651858.CD001500.pub2] - DOI - PubMed
Sweeney 2002 {published data only}
    1. Sweeney C, Bruera E. Communication in cancer care: recent developments. Journal of Palliative Care 2002;18:300-6. - PubMed
Theobald 2002 {published data only}
    1. Theobald DE, Kirsh KL, Holtsclaw E, Donaghy K, Passik SD. An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms. Journal of Pain and Symptom Management 2002;23:442-7. - PubMed
Thompson 2003 {published data only}
    1. Thompson EA, Reilly D. The homeopathic approach to the treatment of symptoms of oestrogen withdrawal in breast cancer patients. A prospective observational study. Homeopathy 2003;92:131-4. - PubMed
van der Meulen 2014 {published data only}
    1. Meulen IC, May AM, Leeuw JR, Koole R, Ooserom M, Hordijk G-J, et al. Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial. British Journal of Cancer 2014;110:593-601. - PMC - PubMed
Vos 2006 {published data only}
    1. Vos JV, Visser AP, Garssen B, Duivenvoorden HJ, Hanneke CJM de Haes. Effects of delayed psychosocial interventions versus early psychosocial interventions for women with early stage breast cancer. Patient Education and Counseling 2006;60:212-9. - PubMed
Warkentin 2006 {published data only}
    1. Warkentin KM, Gray RE, Wassersug RJ. Restoration of satisfying sex for a castrated cancer patient with complete impotence. Journal of Sex and Marital Therapy 2006;32:398-9. - PubMed
Watts 1995 {published data only}
    1. Watts NB, Morris N, Timmons CM, Allen Addison W, Wiita B, Downey LJ. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstetrics and Gynecology 1995;85:529-37. - PubMed
Wei 2005 {published data only}
    1. Wei W, Shuang L, Wu Guang-Jao, Li Li. Influence of perioperative supportive psychotherapy on the postoperative mental state and sexual life in patients with uterine cervix cancer. Chinese Journal of Clinical Rehabilitation 2005;9:42-43.
Wenzel 1999 {published data only}
    1. Wenzel LB, Fairclough DL, Brady MJ, Cella D, Garrett KM, Kluhsman BC, et al. Age-related differences in the quality of life of breast carcinoma patients after treatment. American Cancer Society 1999;86:1768-74. - PubMed
Wenzel 2015 {published data only}
    1. Wenzel L, Osann K, Hsieh S, Tucker JA, Monk BJ, Nelson EL. Psychosocial telephone counseling for survivors of cervical cancer: results of a randomized biobehavioral trial. Journal of Clinical Oncology 2015;33:1171-9. - PMC - PubMed
Wu 2014 {published data only}
    1. Wu J-X, Chen Y. Effect of nursing intervention on mental and physical health in patients with rectal cancer after Miles operation. World Chinese Journal of Digestology 2014;22:1460-4.

References to studies awaiting assessment

Esplen 2014 {published data only}
    1. Esplen MJ, Wong J, Warner E, Toner B. Can we fix what we've broken? Randomized controlled trial of a group therapy to address body image disturbance and sexuality following treatment with breast cancer. In: Canadian Association of Psychosocial Oncology Conference Proceedings. 2014:B-228.
Goetsch 2015 {published data only}
    1. Goetsch M, Lim JY, Caughey AB. A practical solution for dyspareunia in breast cancer survivors: a randomised controlled trial. Journal of Clinical Oncology 2015;33(30):3394-400. [DOI: 10.1200/JCO.2014.60.7366] - DOI - PMC - PubMed
Gremore 2014 {published data only}
    1. Gremore T, Horgan S. A couple-based intervention for patients with head and neck cancer and their partners. Psycho-Oncology 2014;23:42. - PubMed
Hickey 2015 {published data only}
    1. Hickey M, Allardice K. Silicone versus water-based lubricant for symptomatic vaginal dryness after breast cancer: preliminary findings from a randomized trial. Reproductive Sciences 2015;22:55A-390A.
Jensen 2014 {published data only}
    1. Jensen B, Jensen JB. Early rehabilitation can impact on health-related quality of life outcome in radical cystectomy: a randomised controlled trial. Supportive Care in Cancer 2014;22:s185. - PMC - PubMed
Paterson 2015 {published data only}
    1. Paterson C, Lengacher C, Donovan K, Kip K, Tofthagen C. The effects of MBSR (BC) on sexual distress and body image disturbance in breast cancer survivors. Psycho-oncology 2015;24 Suppl 2:287.
Willems 2015 {published data only}
    1. Willems RA, Bolman CAW, Mesters I, Kanera IM, Beaulen AAJM, Lechner L. The Kanker Nazorg Wijzer (Cancer Aftercare Guide) protocol: the systematic development of a web-based computer tailored intervention providing psychosocial and lifestyle support for cancer survivors. BMC Cancer 2014;15:580. - PMC - PubMed

References to ongoing studies

Davis 2015 {published data only}
    1. The effect of 300mcg intravaginal testosterone therapy for the treatment of sexual dysfunction due to Genitourinary Syndrome of Menopause (GSM) in women with breast cancer being treated with an aromatase inhibitor (AI): a randomized placebo controlled trial over 26 weeks. http://apps.who.int/trialsearch/Trial2.aspx?TrialID=ACTRN12615000083594. [ACTRN12615000083594]
DuHamel 2013 {published data only}
    1. DuHamel K, Temple L, Carter J, Schover L, Philip E, Jandorf L, et al. Pilot randomized clinical trial to improve sexual health and quality of life in female rectal and anal cancer survivors. Psycho-Oncology 2013;22:35.
Gessler 2015 {published data only}
    1. Gessler SF, Lanceley A. Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer (SAFFRON). https://clinicaltrials.gov/ct2/show/NCT02458001 2015. [NCT02458001]
Hummel 2015 {published data only}
    1. Hummel SB, Lankveld J. Internet-based cognitive behavioral therapy for sexual dysfunctions in women treated for breast cancer: design of a multicenter, randomized controlled trial. BMC Cancer 2015;15:321. - PMC - PubMed
NCT00459134 2015 {published data only}
    1. Greven K, Wake Forest NCORP Research Base. L-Arginine supplements in treating women who are cancer survivors. https://clinicaltrials.gov/ct2/show/NCT00459134 2007. [NCT00459134]
NCT02091765 2015 {published data only}
    1. Aaronson NK, Lankveld JJDM, Oldenburg HSA, Hahn D. KIS Study: a study evaluating the effectiveness of an internet-based therapy program for sexuality and intimacy problems in women treated for breast cancer. https://clinicaltrials.gov/ct2/show/NCT02091765 2014. [NCT02091765]
Schofield 2013 {published data only}
    1. Schofield P, Juraskova I, Bergin R, Gough K, Mileshkin L, Krishnasamy M, et al. A nurse- and peer-led support program to assist women in gynaecological oncology receiving curative radiotherapy, the PeNTAGOn study (peer and nurse support trial to assist women in gynaecological oncology): study protocol for a randomised controlled trial. Trials 2013;14:39. - PMC - PubMed

Additional references

Allahdadi 2009
    1. Allahdadi KJ, Tostes RCA, Webb RC. Female sexual dysfunction: therapeutic options and experimental challenges. Cardiovascular & Hematological Agents in Medicinal Chemistry 2009;7:260-9. - PMC - PubMed
Ananth 2003
    1. Ananth H, Jones L, King M, Tookman A. The impact of cancer on sexual function: a controlled study. Palliative Medicine 2003;17(2):202-5. - PubMed
Baessler 2009
    1. Baessler K, O'Neill SM, Maher CF, Battistutta D. Australian pelvic floor questionnaire: a validated interviewer-administered pelvic floor questionnaire for routine clinic and research. International Urogynecology Journal and Pelvic Floor Dysfunction 2009;20:149-58. - PubMed
Berman 1999
    1. Berman JR, Berman LA, Werbin TJ, Flaherty EE, Leahy NM, Goldstein I. Clinical evaluation of female sexual function: effects of age and estrogen status on subjective and physiologic sexual responses. International Journal of Impotence Research 1999;11:31-8. - PubMed
Berner 2012
    1. Berner M, Gunzler C. Efficacy of psychosocial interventions in men and women with sexual dysfunctions—a systematic review of controlled clinical trials. Journal of Sexual Medicine 2012;9:3089-107. - PubMed
Bhatt 2006
    1. Bhatt A, Nandipati K, Dhar N, Ulchaker J, Jones S, Rackley R, et al. Neuro- vascular preservation in orthotopic cystectomy: impact on female sexual function. Urology 2006;67(4):742-5. - PubMed
CDC 2011
    1. Centers for Disease Control and Prevention. Cancer survivors - United States, 2007. Morbidity and Mortality Weekly Report. Surveillance Summaries: MMWR 2011;60:269-72. - PubMed
Clayton 1997
    1. Clayton AH, McGarvey EL, Clavet GJ. The Changes in Sexual Functioning Questionnaire. Psychopharmacology Bulletin 1997;33:731-45. - PubMed
Cohen 1998
    1. Cohen AJ, Bartlik B. Ginkgo biloba for antidepressant-induced sexual dysfunction. Journal of Sex Marital Therapy 1998;24:139-43. - PubMed
Conaglen 2010
    1. HM Conaglen, O'Connor EJ, McCabe MP, Conaglen JV. An investigation of sexual dysfunction in female partners of men with erectile dysfunction: how interviews expand on questionnaire responses. International Journal of Impotence Research 2010;22:355-62. - PubMed
Cowan 2013
    1. Cowan ML, Krane MK. Sexual function after radical surgery for rectal cancer. Seminars in Colon and Rectal Surgery 2013;24:164-7.
Craig 2008
    1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:A1655. - PMC - PubMed
Dening 2013
    1. Dening T, Thomas A. Oxford Textbook of Old Age Psychiatry. Second edition. Oxford, 2013.
Derogatis 1979
    1. Derogatis LR, Melisaratos N. The DSFI: a multidimensional measure of sexual functioning. Journal of Sex and Marital Therapy 1979;5:244-81. - PubMed
Derogatis 2008
    1. Derogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. Journal of Sexual Medicine 2008;5:357-64. - PubMed
Donovan 2010
    1. Donovan KA, Thompson LMA, Hoffe SE. Sexual function in colorectal cancer survivors. Cancer Control 2010;17:44-51. - PubMed
DSM‐5 2013
    1. American Psychiatric Association (editors). Diagnostic and Statistical Manual of Mental Disorders. Fifth edition. American Psychiatric Publishing, 2013.
Fruhauf 2013
    1. Fruhauf S, Gerger H, Schmidt HM, Munder T, Barth J. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Archives of Sexual Behavior 2013;42:915-33. - PubMed
Ganz 1998
    1. Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. Journal of Clinical Oncology 1998;16(2):501-14. - PubMed
Goldfarb 2009
    1. Goldfarb SB, Dickler M, Sit L, Fruscione M, Barz T, Atkinson T, et al. Sexual dysfunction in women with breast cancer: prevalence and severity. Journal of Clinical Oncology 2009;15S:9558.
Gonzales 2003
    1. Gonzales GF, Cordova A, Vega K, Chung A, Vilena A, Gonez C. Effect of Lepidium meyenii (Maca), a root with aphtodisiac and fertility-enhancing properties, on serum reproductive hormone levels in adult healthy men. Journal of Endocrinology 2003;176:163-8. - PubMed
Greenwald 2008
    1. Greenwald HP, McCorkle R. Sexuality and sexual function in long-term survivors of cervical cancer. Journal of Women's Health 2008;17:955-63. - PMC - PubMed
Hendren 2005
    1. Hendren SK, O'Connor BL, Liu M, Asano T, Cohen Z, Swallow CJ, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Annals of Surgery 2005;242:212-23. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hill 2011
    1. Hill EK, Sandbo S, Abramsohn E, Makelarski J, Wroblewski K, Wenrich ER, et al. Assessing gynaecologic and breast cancer survivors' sexual health care needs. Cancer 2011;12:2643-51. - PMC - PubMed
Ho 2011
    1. Ho VP, Lee Y, Stein SL, Temple LK. Sexual function after treatment for rectal cancer: a review. Diseases of the Colon and Rectum 2011;54:113-25. - PubMed
Hubayter 2008
    1. Hubayter Z, Simon JA. Testosterone therapy for sexual dysfunction in postmenopausal women. Climacteric 2008;11:181-91. - PubMed
Jackson 2006
    1. Jackson KS, Naik R. Pelvic floor dysfunction and radical hysterectomy. International Journal of Gynecological Cancer 2006;16:354-63. - PubMed
Kazdin 2009
    1. Kazdin AE. Understanding how and why psychotherapy leads to change. Psychotherapy Research 2009;19:418-28. - PubMed
Kedde 2013
    1. Kedde H, de Wiel HB, Weijmar Schultz WC, Wijsen C. Sexual dysfunction in young women with breast cancer. Support Care Cancer 2013;21:271-80. - PubMed
Low 2009
    1. Low C, Fullarton M, Parkinson E. Issues of intimacy and sexual dysfunction following major head and neck cancer treatment. Oral Oncology 2009;45:898-903. - PubMed
Montgomery 2008
    1. Montgomery KA. Sexual desire disorders. Psychiatry 2008;5:50-5. - PMC - PubMed
National Cancer Institute 2012
    1. National Cancer Institute. Sexuality and reproductive issues. http://www.cancer.gov/cancertopics/pdq/supportivecare/sexuality/healthpr... 2012.
Norton 1983
    1. Norton R. Measuring marital quality: a critical look at the dependent variable. Journal of Marriage and the Family 1983;45:141-51.
Ozyilkan 1995
    1. Ozyilkan O, Karaagaoglu E, Topeli A, Kars A, Baltali E, Tekuzman G, et al. A questionnaire for the assessment of quality of life in cancer patients in Turkey. Materia Medica Polona 1995;27(4):153-6. - PubMed
Pignata 2001
    1. Pignata S, Ballatori E, Favalli G, Scambia G. Quality of life: gynaecological cancers. Annals of Oncology 2001;12(Suppl 3):S37-S42. - PubMed
Review Manager 2014 [Computer program]
    1. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rosen 2000
    1. Rosen R, Brown C, Heiman J. The Female Sexual Function Index: a multidimensional self-report instrument for the assessment of female sexual function. Journal of Sex and Marital Therapy 2000;26:191-208. - PubMed
Rust 1985
    1. Rust J, Golombok S. The Golombok-Rust Inventory of Sexual Satisfaction. British Journal of Clinical Psychology 1985;24:63-4. - PubMed
Shin 2010
    1. Shin BC, Lee MS, Yang EJ, Lim HS, Ernst E. Maca (L.meyenii) for improving sexual function: a systematic review. BMC Complementary and Alternative Medicine 2010;10:44. - PMC - PubMed
Singer 2008
    1. Singer S, Danker H, Dietz A. Sexual problems after total or partial laryngectomy. Laryngoscope 2008;118:2218-24. - PubMed
Stead 2007
    1. Stead ML, Fallowfield P, Selby P, Brown JM. Psychosexual function and impact of gynaecological cancer. Best Practice and Research Clinical Obstetrics and Gynaecology 2007;21:309-20. - PubMed
Syrjala 1998
    1. Syrjala KL, Roth Roemer SL, Abrams JR, Scanlan JM, Chapko MK, Visser S, et al. Prevalence and predictors of sexual dysfunction in long-term survivors of marrow transplantation. Blood 1998;16(9):3148-57. - PubMed
Tabano 2002
    1. Tabano M, Condosta D, Coons M. Symptoms affecting quality of life in women with gynaecologic cancer. Seminars in Oncology Nursing 2002;18(3):223-30. - PubMed
Wiggins 2008
    1. Wiggins DL, Dizon DS. Dyspareunia and vaginal dryness after breast cancer treatment. Sexuality Reproduction and Menopause 2008;6:18-22.
Zhang 2013
    1. Zhang Z, Xu X, Ni H. Small studies may overestimate the effect sizes in critical care meta-analyses: a meta-epidemiological study. Critical Care 2013;17:R2. - PMC - PubMed
Zippe 2004
    1. Zippe CD, Raina R, Shah AD, Massanyi EZ, Agarwal A, Ulchaker J, et al. Female sexual dysfunction after radical cystectomy: a new outcome measure. Urology 2004;63:1153-7. - PubMed

References to other published versions of this review

Miles 2005
    1. Miles CL, Jones L, Tookman A, King M. Interventions for sexual dysfunction following treatments for cancer. (Protocol). Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No: CD005540. [DOI: 10.1002/14651858.CD005540] - DOI - PubMed
Miles 2007
    1. Miles C, Candy B, Jones L, Williams R, Tookman A, King M. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No: CD005540. [DOI: 10.1002/14651858.CD005540.pub2] - DOI - PubMed

Publication types

MeSH terms

Substances